R&D Making The World Healthier THROUGH INNOVATION

    주요기술 소개

    AI Platform

    Software Platform

    What is artificial intelligence analysis software for new drug development?
    (IDDS; In silico Drug Design System)
    The process of creating new drugs (basic research, IND registration and preclinical test, clinical trials) is very complex and time consuming. The basic research phase of this process is an important step in determining the success / failure of the next steps in the new drug development process.
    Neolifescience's AI analysis software has the ability to develop various analysis programs as well as virtual simulation analysis for DDS application of compounds, and is conducting research on useful analysis programs required during the development of new drugs.
    What is Natural DDS Library?(NPDL; Natural Product DDS Library)
    Neolifescience has its own DDS technology using natural products. DDS using natural products enables safer drug delivery. We are conducting efficient natural DDS feasibility analysis research through AI analysis technology.
    Neolifescience is currently trying to analyze the chemical structure and physical properties of each natural product by collecting a database of known natural pharmaceutical compounds, and to prove its value as a DDS delivery agent for natural products.
    The natural product DDS Library that we have built through research will increase the prediction accuracy for the application of DDS to new compounds, and utilize it in artificial intelligence analysis to optimize the efficient metabolic delivery process in the human body during the development of new drugs.

    Technology Introduction

    Bio marker identification platform DDS optimization analysis platform

    Bio marker identification platform

    • It is very important to discover biomarkers that regulate disease-causing protein activity during the development of new drugs.
      Neolifescience is conducting drug response analysis through structural binding analysis between proteins and ligands and ADMET analysis, and developing an artificial intelligence analysis platform to discover biomarkers.
      Neolifescience will be able to help improve the success rate of late clinical trials through optimal artificial intelligence algorithms and help discover candidates for new drugs.

    DDS optimization analysis platform

    NPDL(Natural Product DDS Library)

    • We have built a natural product DDS Library to apply the DDS technology of Neolifescience, and based on this information, we can use it for predicting the analysis of natural product based DDS using AI.
      In other words, it is possible to predict whether Neolifescience's DDS technology can be applied by utilizing existing natural products and use it for multi-faceted analysis.